StreetInsider.com News Articles

Truist on AdaptHealth (AHCO): 'Nice Strategic Move As Diabetes Divestiture Announced'

Tue, 21 Jul 2026 08:07:23 -0400

Truist Securities analyst David MacDonald reiterated a Buy rating and $14.00 price target on AdaptHealth (NASDAQ: AHCO).

The analyst commented: "Nice Strategic Move As Diabetes Divestiture Announced; Attractive Strategic Move As AHCO Announces A Definitive Agreement To Divest Its Diabetes Business. After the close, AHCO announced it has entered into a definitive agreement to divest its Diabetes business to Cardinal Health (CAH, NR) for $235M, subject to customary purchase price adjustments. We view the announcement as an attractive strategic move which improves operational focus around the core sleep, respiratory and HME businesses, further centers the portfolio around care delivered within the

Jefferies Upgrades AdaptHealth (AHCO) to Buy

Tue, 21 Jul 2026 07:33:57 -0400

Jefferies analyst Brian Tanquilut upgraded AdaptHealth (NASDAQ: AHCO) from Hold to Buy with a price target of $13.00 (from $11.00).

The analyst comments "Upgrading to Buy on Improved Growth and Earnings Visibility. We upgrade AHCO to Buy based on our view that 1) the co's newly announced, accretive sale of its diabetes business (at ~10x EBITDA, above AHCO's current valuation) removes a long-standing underperforming asset that has driven earnings volatility and weighed on the stock's multiple, and 2) earnings visibility and stability are improving as AHCO continues to win and expand DME capitation agreements with large MCOs. NT, we see potential

Jefferies Upgrades AdaptHealth (AHCO) to Buy

Tue, 21 Jul 2026 07:33:57 -0400

Jefferies analyst Brian Tanquilut upgraded AdaptHealth (NASDAQ: AHCO) from Hold to Buy with a price target of $13.00 (from $11.00).

Cardinal Health to acquire AdaptHealth diabetes unit and Strive Medical for $360M

Mon, 20 Jul 2026 16:46:31 -0400

Cardinal Health (NYSE: CAH) has entered into two definitive agreements to acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ: AHCO) and Strive Medical, a multi-specialty home medical supply provider focused on urology, for a combined approximately $360 million in cash, subject to working capital adjustments.

AdaptHealth's Diabetes Health business serves more than 225,000 patients annually through a centralized, mail-order, direct-to-patient model that delivers supplies such as continuous glucose monitors. Strive Medical serves more than 20,000 patients annually and specializes in urology, wound care, ostomy, and incontinence supplies.

Both transactions are intended to build on Cardinal Health's earlier acquisition of Advanced Diabetes

Cardinal Health to acquire AdaptHealth diabetes unit and Strive Medical for $360M

Mon, 20 Jul 2026 16:46:31 -0400

Both transactions are intended to build on Cardinal Health's earlier acquisition of Advanced Diabetes

Cardinal Health to acquire AdaptHealth diabetes unit and Strive Medical for $360M

Mon, 20 Jul 2026 16:46:31 -0400

Both transactions are intended to build on Cardinal Health's earlier acquisition of Advanced Diabetes

Cardinal Health to acquire AdaptHealth diabetes unit and Strive Medical for $360M

Mon, 20 Jul 2026 16:46:31 -0400

Both transactions are intended to build on Cardinal Health's earlier acquisition of Advanced Diabetes

Cardinal Health expands home care business with two tuck-in acquisitions

Mon, 20 Jul 2026 16:45:00 -0400